| Model: | Residual |
| Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
| TSHA | Taysha Gene Therapies Inc | Healthcare | Biotechnology | 1169 | 4.07 | 4013339 | |
| ABSI | Absci Corp | Healthcare | Biotechnology | 425 | 2.76 | 4625378 |
| Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
| Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
| Regression Per: | 15 | ||||
| Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
| Version: | 5 | Model Version: | 2013.1 | Bid-Ask 0.01 / 0.01 | |
| Initial Capital: | 10000.00 | Final Equity: | 9297.30 |
| Total net P/L: | -702.70 | Total ROI: | -7.03 % |
| CAGR: | -1.59 % | Max. DD: | 90.03 % |
| System Score: | -0.003 | Sharpe Ratio: | 1.087 |
| Start Date: | 2021-08-12 | End Date: | 2026-02-27 |
| Total days: | 1660 | ||
| Commissions: | 6125.48 | Comm.% P/L | 112.96 % |
| Total Transactions: | 260 | Log. Linearity: | 12.363 % |
| Total | Long |
Short |
TSHA | ABSI | |
|---|---|---|---|---|---|
| Total Profit/Loss | 5422.78 | 159.00 | 5263.78 | 20068.31 | -14645.53 |
| Total Profit | 57730.64 | 30030.41 | 27700.23 | 51805.66 | 35951.56 |
| Total Loss | 52307.86 | 29871.41 | 22436.45 | 31737.35 | 50597.10 |
| Profit Factor | 1.10 | 1.01 | 1.23 | 1.63 | 0.71 |
| Trades | 65 | 33 | 32 | 65 | 65 |
| Winning Trades | 42 | 20 | 22 | 45 | 30 |
| Losing Trades | 23 | 13 | 10 | 19 | 35 |
| % Profitable | 64.00 | 60.00 | 68.00 | 69.00 | 46.00 |
| Profit/Loss Per Trade % | 0.65 | 0.57 | 0.74 | 2.43 | -2.17 |
| Profit Per Trade % | 12.57 | 13.84 | 11.43 | 10.50 | 10.68 |
| Loss Per Trade % | 15.86 | 15.47 | 16.37 | 12.53 | 11.25 |
| Days In Trade | 681 | 387 | 294 | 681 | 681 |
| Days In Trade (Avg. Per Trade) | 10.48 | 11.73 | 9.19 | 10.48 | 10.48 |
| % Days In Trade | 41.02 | 23.31 | 17.71 | 41.02 | 41.02 |